We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

42 hedge funds and large institutions have $79.2M invested in Jasper Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 5

27% more funds holding

Funds holding: 33 → 42 (+9)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

11% more capital invested

Capital invested by funds: $71.2M → $79.2M (+$7.99M)

Holders
42
Holders Change
+9
Holders Change %
+27.27%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
7
Closed
5
Calls
$194K
Puts
–
Net Calls
+$194K
Net Calls Change
+$24K

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$5.62M
2
Goldman Sachs
Goldman Sachs
New York
+$5.19M
3
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$4.75M
4
RCM
Rivernorth Capital Management
Florida
+$1.93M
5
BCM
Beryl Capital Management
California
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
-$8.82M
2
AA
AQR Arbitrage
Connecticut
-$2.31M
3
LIM
Longfellow Investment Management
Massachusetts
-$1.93M
4
MIM
Monashee Investment Management
Massachusetts
-$1.79M
5
UOC
UBS O'Connor
Illinois
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$10.3M +$5.62M +56,248 +118%
Goldman Sachs
2
Goldman Sachs
New York
$5.15M +$5.19M +51,926 New
TCM
3
Tenor Capital Management
New York
$4.96M – – –
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$4.71M – – –
PSAMP
5
P. Schoenfeld Asset Management (PSAM)
New York
$4.71M +$4.75M +47,500 New
SRCM
6
Sage Rock Capital Management
New York
$4.6M +$571K +5,716 +14%
UOC
7
UBS O'Connor
Illinois
$4.54M -$1.14M -11,375 -20%
PMAM
8
Picton Mahoney Asset Management
Ontario, Canada
$3.72M – – –
FTCM
9
Fir Tree Capital Management
New York
$3.58M +$112K +1,123 +3%
DCM
10
Dupont Capital Management
Delaware
$2.98M – – –
AIMCA
11
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.79M – – –
RCM
12
Radcliffe Capital Management
Pennsylvania
$2.75M +$98.9K +990 +4%
BCM
13
Beryl Capital Management
California
$2.53M +$1.62M +16,221 +175%
BI
14
Bulldog Investors
New Jersey
$2.46M -$17.5K -175 -0.7%
RCM
15
Rivernorth Capital Management
Florida
$1.92M +$1.93M +19,342 New
MSU
16
Mizuho Securities USA
New York
$1.72M -$365K -3,655 -17%
BCM
17
Basso Capital Management
Connecticut
$1.4M +$715K +7,158 +103%
LA
18
Linden Advisors
New York
$1.3M – – –
KIM
19
Karpus Investment Management
New York
$1.3M -$16K -160 -1%
Verition Fund Management
20
Verition Fund Management
Connecticut
$1.12M +$127K +1,274 +13%
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$1.1M – – –
PC
22
Periscope Capital
Ontario, Canada
$996K – – –
Walleye Capital
23
Walleye Capital
New York
$983K +$989K +9,900 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
24
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$930K – – –
YCM
25
Yakira Capital Management
Connecticut
$827K +$833K +8,333 New
1
2

JSPR Hedge Fund Activity: Q3 2020 in Review

42 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q3 2020, worth a combined $79.2M — up 11% from $71.2M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new JSPR positions and 5 closed out — a net gain of 9 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $5.62M. The largest seller was Owl Creek Asset Management, exiting entirely with an estimated $8.82M sold.

  • 42 institutional investors held Jasper Therapeutics (JSPR) as of Q3 2020, up from 33 in Q2 2020.
  • Funds reported $79.2M of Jasper Therapeutics stock for Q3 2020, up 11% quarter-over-quarter.
  • 14 funds opened new Jasper Therapeutics positions in Q3 2020 and 5 closed out, a net change of +9 holders.
  • The largest Jasper Therapeutics buyer in Q3 2020 was Glazer Capital LLC, an estimated $5.62M added.
  • The largest Jasper Therapeutics seller in Q3 2020 was Owl Creek Asset Management, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2020.